Do you want to help shape the future of treatments for sickle cell disease (SCD)?
On January 27, 2027, the Sickle Cell Voices Alliance, a partnership among the Sickle Cell Disease Association of America, Inc., the Sickle Cell Disease Association of Canada and the Sickle Cell Society, UK, is hosting an Externally-Led Patient-Focused Drug Development meeting about sickle cell disease (SCD). This is an opportunity for the U. S. Food and Drug Administration (FDA) and other key stakeholders and regulatory authorities to hear directly from sickle cell warriors and caregivers about how living with SCD affects their daily lives and treatment preferences.
We want to amplify the comments that will be made at this virtual meeting by surveying the community to share many perspectives with the FDA and other key stakeholders and regulatory authorities.
Please take our 10-minute survey below - this survey is only for sickle cell warriors and caregivers. Thank you for helping to shape the future of SCD treatments!